Table 1. Demographic and clinical characteristics of total study population.

Variables
Male/female	75/54
Age (y), mean ± SD	64.2 ± 11.6
BMI (kg/m2), mean ± SD	29.7 ± 13.5
Current smokers, n (%)	18 (14)
Diabetes, n (%)	39 (30)
Dyslipidemia, n (%)	82 (64)
Concomitant medication
Aspirin, n (%)	68 (53)
Statin/bezafibrate, n (%)	69 (54)
β-blocker, n (%)	66 (51)
ACE/ARB, n (%)	97 (75)
Diuretic, n (%)	47 (36)
CC blocker, n (%)	66 (51)
Systolic blood pressure (mm Hg), mean ± SD	143.8 ± 14.8
Diastolic blood pressure (mm Hg), mean ± SD	76.9 ± 9.6
Mean arterial pressure (mm Hg), mean ± SD	101.3 ± 12.7
Fasting blood glucose (mg/dL), mean ± SD	115.8 ± 34.4
HbA1C (%), mean ± SD	6.4 ± 1.0
Total cholesterol (mg/dL), mean ± SD	182.6 ± 40.0
LDL cholesterol (mg/dL), mean ± SD	120.1 ± 61.7
HDL cholesterol (mg/dL), mean ± SD	46.3 ± 12.0
Triglycerides (mg/dL), mean ± SD	144.2 ± 80.1
Hs-CRP (mg/dL), mean ± SD	0.7 ± 1.6
Fasting insulin (IU/mL), mean ± SD	12.6 ± 6.3
HOMA-IR, mean ± SD	3.5 ± 1.9
Homocysteine (μmol/L), mean ± SD	13.5 ± 8.6
Plasma aldosterone (ng/mL), mean ± SD	8.3 ± 5.6
Plasma renin (ng/mL), mean ± SD	1.6 ± 2.1
Urinary MA/creatinine (mg/g), mean ± SD	58.1 ± 186.9
Endothelin (fmol/mL), mean ± SD	0.3 ± 0.6
Left ventricular mass (g), mean ± SD	245.5 ± 83.3
LVMI (g/m2), mean ± SD	127.0 ± 39.1
IVST (cm), mean ± SD	1.43 ± 0.5
PWT (cm), mean ± SD	0.63 ± 0.17
LV end-diastolic diameter (cm), mean ± SD	4.8 ± 0.6
LV end-systolic diameter (cm), mean ± SD	2.9 ± 0.6

Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; CC, calcium channel; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; hs-CRP, high-sensitivity C-reactive protein; IVST, interventricular septum thickness; LDL, low-density lipoprotein; LV, left ventricular; LVMI, left ventricular mass index; MA, microalbumin; PWT, posterior wall thickness; SD, standard deviation.